International Journal of
Environmental Research
and Public Health
Article
Modification of the Association between Visual
Impairment and Mortality by Physical Activity:
A Cohort Study among the Korean National
Health Examinees
Kyoung-NamKim1,2,SangJunPark2,3 ,WoosungKim2,JungminJoo1,HaebinKim4,
KyaeHyungKim1,5 ,JiHoonSohn1,6andYongJinKwon1,7,*
1 DivisionofPublicHealthandPreventiveMedicine,SeoulNationalUniversityHospital,Seoul03080,Korea;
kkn002@snu.ac.kr(K.-N.K.);jungmin.alice.joo@gmail.com(J.J.);kyaehyungkim.snuh@gmail.com(K.H.K.);
eliarde@naver.com(J.H.S.)
2 DepartmentofPreventiveMedicine,SeoulNationalUniversityCollegeofMedicine,Seoul03080,Korea;
sanjunpark@snu.ac.kr(S.J.P.);kimsong85@snu.ac.kr(W.K.)
3 DepartmentofOphthalmology,SeoulNationalUniversityBundangHospital,SeoulNationalUniversity
CollegeofMedicine,Seongnam13620,Korea
4 DepartmentofPsychiatry,KyungHeeUniversityHospital,Seoul02447,Korea;haebins1001@gmail.com
5 DepartmentofFamilyMedicine,SeoulNationalUniversityCollegeofMedicine,Seoul03080,Korea
6 DepartmentofPsychiatryandBehavioralScience,SeoulNationalUniversityCollegeofMedicine,
Seoul03080,Korea
7 DepartmentofForensicMedicine,SeoulNationalUniversityCollegeofMedicine,Seoul03080,Korea
* Correspondence: 301kwon@snuh.org;Tel.:+82-2-2072-0373
(cid:1)(cid:2)(cid:3)(cid:1)(cid:4)(cid:5)(cid:6)(cid:7)(cid:8)(cid:1)
(cid:1)(cid:2)(cid:3)(cid:4)(cid:5)(cid:6)(cid:7)
Received: 30July2019;Accepted: 8November2019;Published: 10November2019
Abstract: The association between visual impairment and higher mortality remains unclear.
Inaddition,evidenceislackingontheinteractionbetweenvisualfunctionandphysicalactivityon
mortality. Weuseddataofindividualswithnodisabilityorwithvisualimpairmentamongthosewho
participatedintheNationalHealthScreeningPrograminKoreain2009or2010. WeconstructedCox
proportionalhazardmodelsadjustedforpotentialconfounderstoevaluatetheindependentassociation
betweenvisualimpairmentandmortality. Moreseverevisualimpairmentwasassociatedwithhigher
all-causemortality(p-valuefortrend=0.03)andmortalityduetocardiovasculardiseases(p-valuefor
trend=0.02)andthatduetootherdiseases(p-valuefortrend=0.01). Wefoundaninteractiononan
additivescalebetweenvisualimpairmentandnophysicalactivityonall-causemortality(relative
excessriskduetointeraction=1.34,95%confidenceinterval: 0.37,2.30,p-value=0.01). Whenwe
stratifiedthestudypopulationbyphysicalactivity,theassociationbetweenvisualimpairmentand
mortalitywasonlyfoundamongindividualswhodidnotengageinregularphysicalactivity(p-value
fortrend=0.01). Wefoundanindependentassociationbetweenvisualimpairmentandmortality
andmodificationofthisassociationbyphysicalactivity.
Keywords: visualimpairment;blindness;mortality;physicalactivity;interaction
1. Introduction
Visualimpairmentlowersthehealth-relatedqualityoflifeandindependenceinactivitiesofdaily
living [1,2] and leads to adverse health outcomes such as depression and fractures, resulting in a
considerablesocioeconomicburden[3]. Globally,in2015,441.1millionpeoplewereestimatedtohave
visualimpairment. Duetoworldwidepopulationaging,thenumberofpeoplewithvisualimpairment
Int.J.Environ.Res.PublicHealth2019,16,4386;doi:10.3390/ijerph16224386 www.mdpi.com/journal/ijerph
Int.J.Environ.Res.PublicHealth2019,16,4386 2of12
hasbeensharplyincreasing(35.5%increaseformoderateorseverevisualimpairmentfrom1990to
2015)[4]. Visualimpairmenthasemergedasapublichealthconcernduringthelastdecades.
Therefore, the effects of visual impairment on health, physical activity, chronic diseases, and
mortalityshouldbeelucidatedtomitigateitsburdenonindividuals,communities,andthehealthcare
system. However,unlikeothers,theeffectofvisualimpairmentonmortalityhaspuzzledresearchers;
somestudieshavereportedanincreasedmortalityinindividualswithvisualimpairment[5–11],while
othershavenot[12–16]. Inaddition,asvisualimpairmentexacerbatestheimpactofchronicconditions
onhealth-relatedqualityoflife[1],theassociationbetweenvisualimpairmentandmortalityshouldbe
investigatedconsideringthepossibleinteractionbetweenhealth-relatedconditionsincludingphysical
activity, whichisoneofthemodifiablefactorsaffectingmortalityinindividualswithdeteriorated
vision. Physicalactivityhasbeenshowntolowermortalityinvariouspopulations,and,therefore,
theassociationbetweenvisualfunctionandmortalitymaydifferbyphysicalactivitystatus. However,
evidenceislackingontheinteractionbetweenvisualfunctionandphysicalactivitywithregardto
mortality[5].
Therefore,inthepresentstudy,wehypothesizedthatvisualimpairmentwouldbeindependently
associatedwithincreasedmortalityandthatphysicalactivitywouldmodifytheassociationbetween
visualfunctionandmortality. WeevaluatedthesehypothesesusingacohortoftheKoreannational
healthexaminees.
2. MaterialsandMethods
2.1. StudyParticipants
We used data from the National Health Insurance Service-National Health Screening Cohort
(NHIS-HEALS)oftheRepublicofKorea,whichhasbeenconstructedbytheNHIStoenhancepublic
research. The study protocol and detailed information of the NHIS-HEALS has been published
elsewhere [17]. In brief, a random sample of the participants in the National Health Screening
Program,whichisfreeandinvitesallresidentsaged≥40yearsintheRepublicofKoreaatleastevery
2years,constitutesthiscohort(n=514,866). Informationonsociodemographicfactors,lifestyle,past
medicalhistory,physicalexaminations,clinicallaboratorytestresults,andmortalityareincludedin
theNHIS-HEALS.
Inthepresentstudy,weuseddataof362,285individualswhoparticipatedintheNationalHealth
ScreeningProgramin2009or2010becausethehealthscreeningprogramwasreorganizedin2009
andthenumberofsurveyitemsincreasedfrom33to47inthatyear. Wefurtherexcludedindividuals
with physical (n = 687), auditory (n = 463), language (n = 209), intellectual (n = 117), and mental
(n=93)disabilities,brainlesions(n=328),andothertypesofdisability(includingdevelopmental,
kidney,heart,andliverdisabilities)(n=404),leadingtoafinalsamplesizeof359,984individuals.
WeusedinformationondisabilitiesfromtheNationalHandicappedRegistry,whichwasprovidedto
researchersbytheNHIS-HEALS.Thefinalstudypopulationcomprised359,523individualswithno
disabilitiesand461withvisualimpairment.
The Ethics Review Board of Seoul National University Hospital reviewed and approved the
protocol of this study (E-1804-045-936). We conducted the present study using de-identified data
(NHIS-HEALS)releasedtoresearchersforthepurposeofpublicresearch.
2.2. VisualImpairment
IntheRepublicofKorea,individualsdiagnosedwithvisualimpairmentbyamedicaldoctorare
registeredintheNationalHandicappedRegistrytoreceivedisabilitybenefits. Visualimpairmentis
assessedbythediagnosingphysiciansonsixgradesaccordingtoseverity[18]. Althoughindividuals
withvisualimpairmentwereassessedas6grades(grade1tograde6)intheNationalHandicapped
Registry,theNHIS-HEALSprovidesinformationonthegradeofvisualimpairmentonlyas“severe”
(grade1or2)and“mild”(grades3–6)duetoconfidentialityissue. Becauseindividualswhohavea
Int.J.Environ.Res.PublicHealth2019,16,4386 3of12
best-correctedvisualacuityof≤0.02(20/1000)inthebetter-seeingeyeareclassifiedasgrade1andthose
withbest-correctedvisualacuityof0.02–0.04(20/1000–20/500)inthebetter-seeingeyeasgrade2,severe
visualimpairmentwasdefinedasbest-correctedvisualacuity≤0.02(20/1000)inthebetter-seeingeye
inthepresentstudy. Meanwhile,mildvisualimpairmentwasdefinedasabest-correctedvisualacuity
of0.06–0.2(6/100–20/100)inthebetter-seeingeye,≤0.02(20/1000)intheworse-seeingeye,oranyvisual
fielddefects(grades3–6)inthepresentstudy.
We coded a variable for visual impairment as 0 (no visual impairment, reference), 1 (mild
visual impairment), and 2 (severe visual impairment) and used it in further analyses as an
independentvariable.
2.3. PhysicalActivity
InformationonphysicalactivityisobtainedintheNHIS-HEALSusingaself-reportedquestionnaire
inquiringonthefrequencyofleisure-timeexercise≥20min,whichcausesrapidbreathing(e.g.,running,
aerobics,fastcycling,ormountainclimbing),correspondingtovigorous-intensityphysicalactivity.
Wecategorizedthefrequencyofphysicalactivity(day/week)asnone(0day/week),1or2days/week,
3 or 4 days/week, or ≥5 days/week and used the categorized frequency of physical activity in
furtheranalyses.
2.4. All-CauseandCause-SpecificMortality
Weobtainedinformationondatesandcausesofdeathoccurringbetween1January2010and
31 December 2013. Statistics Korea provided the information on mortality, and the NHIS merged
thisinformationwiththeotherdatausingpersonalidentificationnumbers. Wecategorizedcauseof
deathasdeathcausedbycardiovasculardisease(definedasInternationalClassificationofDisease,
10thRevision[ICD-10]codesI20–I25,I50,andI60–I70),cancer(C00–C97),andothercauses,according
toapreviousstudy[6].
2.5. AssumedCausalPathwayandAdjustedCovariates
We assumed a causal pathway for the association between visual impairment and mortality
as depicted in Figure 1, based on previous studies [5–9,12–14,19–22], to assess the independent
association by identifying potential confounders and mediators. In brief, we selected older age,
systematic diseases and conditions (body mass index, waist circumference, systolic and diastolic
blood pressure, serum levels of fasting glucose, creatinine, aspartate aminotransferase, alanine
aminotransferase,andgammaglutamyltransferase,andhistoryofstroke,heartdisease,hypertension,
type 2 diabetes, dyslipidemia, and other diseases including cancer), income, residing area, and
lifestyle factors (smoking status and alcohol consumption) as potential confounders, which could
affectbothvisualfunctionandmortalityandpossiblybiastheresults. Afteridentifyingthepotential
confounders,weadjustedtheminfurtheranalyses. Wedidnotadjustforphysicalactivityinthemain
modelsbecausephysicalactivitymaymediatetheassociationbetweenvisualfunctionandmortality
partially(Figure1)[5,19,21]andtheassociationbetweenvisualimpairmentandmortalitycouldbe
underestimatedwhenadjustingforphysicalactivity. Detailedinformationonselectedcovariatesis
presentedintheSupplementaryMaterial.
Int.J.Environ.Res.PublicHealth2019,16,4386 4of12
Int. J. Environ. Res. Public Health 2019, 16, x 4 of 12
Figure1. Directedacyclicgraphfortheassociationbetweenvisualimpairmentandmortality.
Figure 1. Directed acyclic graph for the association between visual impairment and mortality.
2.6. StatisticalAnalysis
2.6. Statistical Analysis
Aftervisuallycheckingthatsurvivalcurvesdidnotcrossbyvisualfunction(novisualimpairment,
After visually checking that survival curves did not cross by visual function (no visual impairment,
mildvisualimpairment,andseverevisualimpairment)usingtheKaplan–Meiercurves(Supplemental
mild visual impairment, and severe visual impairment) using the Kaplan–Meier curves (Supplemental
MaterialFigureS1),weconstructedCoxproportionalhazardmodelsadjustedforpotentialconfounders
Material Figure S1), we constructed Cox proportional hazard models adjusted for potential
toevaluatetheassociationbetweenvisualimpairmentandall-causemortality. Wealsoconstructed
confounders to evaluate the association between visual impairment and all-cause mortality. We also
cause-specificproportionalhazardmodelsadjustedforthesamecovariatestoassesstheassociations
constructed cause-specific proportional hazard models adjusted for the same covariates to assess the
between visual impairment and cause-specific mortality (mortality due to cardiovascular disease,
associations between visual impairment and cause-specific mortality (mortality due to cardiovascular
cancer,orotherdiseases). Weestimatedp-valuesfortrendbytreatingthevariableforvisualimpairment
disease, cancer, or other diseases). We estimated p-values for trend by treating the variable for visual
asacontinuousvariable,notasanordinalone. Wealsoconductedthesameanalysesfurtheradjusted
fi om rp pa hir ym sie cn alt aa cs
t
ia
v
ic tyon (nti on nu eo ,u 1s
–
2v ,a 3ri –a 4b ,l oe,
r
n≥o 5t tia ms ea sn/w o er ed kin ).al one. We also conducted the same analyses
further adjusted for physical activity (none, 1–2, 3–4, or ≥5 times/week).
WethenconductedstratifiedanalysisusingthesameCoxmodelsbythehouseholdincomelevels
We then conducted stratified analysis using the same Cox models by the household income
(0–3 deciles as lower income level, 4–7 as middle income level, and 8–10 as higher income level),
levels (0–3 deciles as lower income level, 4–7 as middle income level, and 8–10 as higher income
sex,andbodymassindex(≥23kg/m2 and<23kg/m2)toidentifyvulnerablegroupsfordecreased
level), sex, and body mass index (≥23 kg/m2 and <23 kg/m2) to identify vulnerable groups for
visualfunction.
decreased visual function.
We investigated whether physical activity would modify the association between visual
We investigated whether physical activity would modify the association between visual
impairment and mortality. It has been argued that interaction on an additive scale, rather than
impairment and mortality. It has been argued that interaction on an additive scale, rather than that
thatonamultiplicativescale,ismoresuitableforevaluatingbiologicalinteractions[23]. Therefore,
on a multiplicative scale, is more suitable for evaluating biological interactions [23]. Therefore, we
weestimatedameasureforadditiveinteraction(i.e.,relativeexcessriskduetointeraction(RERI)).
estimated a measure for additive interaction (i.e., relative excess risk due to interaction (RERI)). If the
IftheriskofcertainoutcomeforexposureX isAandtheriskofoutcomeforexposureX isB,then
1 2
tr his ek
R
o Ef Rce Ir it sai gn
r
eo au tt ec ro tm hae
n
fo zr
e
e roxp inos cu ar se
e
X t1
h
i es rA
is
kan od
f
oth ue
t
cr ois mk
e
o nf oo tu et dco am se
C
fo isr gex rep ao ts eu rr te
h
aX n2 i As B +, t Bhe wn
h
t eh ne
RERI is greater than zero in case the risk of outcome noted as C is greater than A + B when
simultaneouslyexposedtoX andX (RERI=C−(A+B)).
1 2
simu Tlt oan ce oo nu ds uly ct e tx hp io ss ae nd a t lo y sX is1 ,a wnd e X re2 -( cR aE teR gI o = r iC ze − d (A ph + y B si) c) a. l activity as no or yes (≥once/week) and
To conduct this analysis, we re-categorized physical activity as no or yes (≥once/week) and
assignedyes(≥once/week)asareferencebecauseithasbeenreportedthatpreventivefactors(e.g.,
assigned yes (≥once/week) as a reference because it has been reported that preventive factors (e.g.,
physical activity) should be recoded as risk factors to adequately estimate measures for additive
physical activity) should be recoded as risk factors to adequately estimate measures for additive
interaction[24]. Wealsore-categorizedvisualimpairmentasnooryes(collapsedthecategoriesfor
interaction [24]. We also re-categorized visual impairment as no or yes (collapsed the categories for
severeandmildvisualimpairment)andestimatedtheRERIbetweenvisualimpairment(nooryes)
severe and mild visual impairment) and estimated the RERI between visual impairment (no or yes)
andphysicalactivity(nooryes)usinglogisticregressionmodelsadjustedforthesamecovariates.
and physical activity (no or yes) using logistic regression models adjusted for the same covariates.
WeassessedthenullhypothesisthatRERI=0usingtheZ-testandestimatedtheconfidenceinterval
We assessed the null hypothesis that RERI = 0 using the Z-test and estimated the confidence interval
(CI)andp-value[24]. BecauseaRERIscore>0denotesgreaterriskthanthesumofeachmaineffectin
(CI) and p-value [24]. Because a RERI score >0 denotes greater risk than the sum of each main effect
thecasewhenexposuresoccursimultaneously,inthepresentstudy,aRERIscore>0canbeinterpreted
in the case when exposures occur simultaneously, in the present study, a RERI score >0 can be
interpreted as higher mortality due to interaction compared to the additive effects of both visual
Int.J.Environ.Res.PublicHealth2019,16,4386 5of12
ashighermortalityduetointeractioncomparedtotheadditiveeffectsofbothvisualimpairmentand
nophysicalactivity. Weassessedtheassociationbetweenvisualimpairmentandmortalityineach
stratumstratifiedbyphysicalactivity(noneand≥once/week).
In sensitivity analyses, we performed analyses after excluding individuals diagnosed with
vision-threateningconditionssuchasdetachmentofretinalpigmentepithelium(H33.0,H33.1,H33.2,
H33.3, H33.4, andH33.5), centralretinalarteryocclusion(H34.1), degenerationofthemaculaand
posteriorpole(H35.3),opticneuropathy(H46),visualdisturbances(H53.0,H53.2,H53.2,H53.3,H53.4,
H53.5,H53.6,H53.8,andH53.9),andvisualimpairment(H54.0,H54.1,H54.2,H54.3,H54.4,H54.6,
andH54.9)between2002and2010(n=25,782)amongthoseclassifiedinthenovisualimpairment
group. Finally,weconductedanalysesfurtherincludingindividualswithphysical,auditory,language,
intellectual, andmentaldisabilities, brainlesions, andothertypesofdisabilityclassifiedintheno
visualimpairmentgroup.
We performed the analyses using SAS version 9.4 (SAS Institute Inc., Cary, NC, USA) and R
version3.5.2(TheComprehensiveRArchiveNetwork,Vienna,Austria;http://cran.r-project.org).
3. Results
Weanalyzedthedataof359,523individualswithnovisualimpairment,328withmildvisual
impairment,and133withseverevisualimpairmentinthepresentstudy. Comparedwithindividuals
withnovisualimpairment,thosewithvisualimpairmentweremorelikelytobeolder(71.5yearsvs.
59.0years),notexerciseregularly(78.4%vs. 59.3%),andhavehistoryofstroke(6.5%vs. 1.8%),heart
disease(8.4%vs. 4.7%),hypertension(51.3%vs. 36.5%),andtype2diabetes(21.2%vs. 12.1%)(Table1).
Table1. Sociodemographiccharacteristicsofthestudyparticipantsbyvisualfunction(n=359,984).
NoVisualImpairment MildVisual SevereVisual
Characteristics (n=359,523) Impairment(n=328) Impairment(n=133) p-Valuea
Sex
Men 194,785(54.2) 197(60.1) 70(52.6) 0.10
Women 164,738(45.8) 131(39.9) 63(47.4)
Householdincome(deciles)
0–3 73,251(20.4) 80(24.4) 25(18.8) 0.41
4–7 115,402(32.1) 104(31.7) 46(34.6)
8–10 170,870(47.5) 144(43.9) 62(46.6)
Bodymassindex(kg/m2)
<18.5 7848(2.2) 19(5.8) 7(5.3) <0.01
18.5–22.9 125,809(35.0) 114(34.8) 48(36.1)
23–24.9 100,866(28.1) 93(28.4) 32(24.1)
≥25 124,894(34.8) 102(31.1) 46(34.6)
Smokingstatus
Non-smoker 227,957(64.5) 229(70.0) 89(68.5) 0.04
Ex-smoker 65,591(18.5) 63(19.3) 21(16.2)
Smoker 60,142(17.0) 35(10.7) 20(15.4)
Alcoholconsumption
None 215,080(60.3) 234(71.6) 99(74.4) <0.01
1–2times/week 91,879(25.7) 47(14.4) 20(15.0)
3–4times/week 32,086(9.0) 21(6.4) 8(6.0)
≥5times/week 17,876(5.0) 25(7.7) 6(4.5)
Physicalactivity
None 211,833(59.3) 258(79.1) 101(76.5) <0.01
1–2times/week 78,179(21.9) 36(11.0) 20(15.2)
3–4times/week 39,323(11.0) 7(2.2) 3(2.3)
≥5times/week 28,044(7.9) 25(7.7) 8(6.1)
Historyofstroke
No 253,662(98.2) 251(93.7) 97(93.3) <0.01
Yes 4638(1.8) 17(6.3) 7(6.7)
Historyofheartdisease
No 246,268(95.3) 246(92.1) 94(90.4) <0.01
Yes 12,137(4.7) 21(7.9) 10(9.6)
Historyofhypertension
No 164,856(63.5) 133(49.4) 49(46.7) <0.01
Yes 94,633(36.5) 136(50.6) 56(53.3)
Int.J.Environ.Res.PublicHealth2019,16,4386 6of12
Table1. Cont.
NoVisualImpairment MildVisual SevereVisual
Characteristics (n=359,523) Impairment(n=328) Impairment(n=133) p-Valuea
Historyoftype2diabetes
No 227,279(87.9) 212(79.1) 82(78.1) <0.01
Yes 31,401(12.1) 56(20.9) 23(21.9)
Historyofdyslipidemia
No 242,507(93.8) 251(94.0) 98(92.5) 0.84
Yes 16,087(6.2) 16(6.0) 8(7.6)
Historyofotherdiseases
includingcancer
No 229,876(88.9) 219(82.0) 88(84.6) <0.01
Yes 28,576(11.1) 48(18.0) 16(15.4)
Age(years) 59.0±8.8 72.5±8.8 68.9±9.2 <0.01
Waistcircumference(cm) 82.0±8.2 83.0±8.9 82.9±8.5 0.05
Systolicbloodpressure(mmHg) 125.3±15.2 130.5±16.3 129.1±16.3 <0.01
Diastolicbloodpressure(mmHg) 77.6±9.9 78.6±9.9 77.9±10.8 0.18
Fastingserumglucoselevel(mg/dL) 101.2±25.3 106.7±32.1 104.4±26.2 <0.01
Serumcreatininelevel(mg/dL) 1.1±1.2 1.1±1.0 1.0±1.0 0.94
ASTlevel(U/L) 26.5±18.4 25.9±10.0 27.4±14.3 0.71
ALTlevel(U/L) 25.1±19.1 21.9±12.1 23.2±15.6 <0.01
γ-GTlevel(U/L) 38.2±53.6 30.9±23.8 36.1±36.6 0.04
Note. ALT=alanineaminotransferase;AST=aspartateaminotransferase;γ-GT=gammaglutamyltransferase.
Valuesarepresentedasn(%)forcategoricalvariablesandmean±standarddeviationforcontinuousvariables.
ap-valueswereestimatedbyChi-squaretestforcategoricalvariablesandANOVAtestforcontinuousvariables.
Becauseonly461individualswithvisualimpairmentwereincludedcomparedwith359,523with
novisualimpairment,wecontrolledforextensiveaforementionedcovariatesinfurtheranalyses,to
increase the comparability between individuals with no visual impairment and those with visual
impairment. Afteradjustingforpotentialconfounders,moreseverevisualimpairmentwasassociated
withhigherall-causemortality(p-valuefortrend=0.03)andmortalityduetocardiovascular(p-value
fortrend=0.02)andduetootherdiseases(p-valuefortrend=0.01). Severevisualimpairmentwas
associatedwithall-causemortality(hazardratio[HR]=1.90,95%CI:1.08,3.35)andmortalitydueto
cardiovasculardisease(HR=1.84,95%CI:1.04,3.23)comparedwithnovisualimpairment(Table2).
Whenweconductedanalysesfurtheradjustedforphysicalactivity,therewerenomarkedchangesin
theresults(Table2).
Table 2. Associations between visual impairment and mortality among the Korean national
healthexaminees.
VisualFunction No. ofDeaths HR 95%CI p-ValueforTrend
Analysesnotadjustedforphysicalactivitya
All-causemortality
Novisualimpairment 8211 Ref. Ref. 0.03
Mildvisualimpairment 34 1.17 0.81,1.69
Severevisualimpairment 16 1.90 1.08,3.35
Mortalityduetocardiovasculardiseases
Novisualimpairment 1202 Ref. Ref. 0.02
Mildvisualimpairment 6 1.22 0.85,1.76
Severevisualimpairment 5 1.84 1.04,3.23
Mortalityduetocancers
Novisualimpairment 3415 Ref. Ref. 0.34
Mildvisualimpairment 9 0.83 0.39,1.74
Severevisualimpairment 2 0.44 0.06,3.10
Mortalityduetootherdiseases
Novisualimpairment 3504 Ref. Ref. 0.01
Mildvisualimpairment 19 1.60 1.00,2.54
Severevisualimpairment 9 2.20 0.99,4.90
Int.J.Environ.Res.PublicHealth2019,16,4386 7of12
Table2. Cont.
VisualFunction No. ofDeaths HR 95%CI p-ValueforTrend
Analysesfurtheradjustedforphysicalactivityb
All-causemortality
Novisualimpairment 8211 Ref. Ref. 0.03
Mildvisualimpairment 34 1.16 0.81,1.67
Severevisualimpairment 16 1.87 1.06,3.29
Int. J. Environ. Res. Public Health 2019, 16, x 7 of 12
Mortalityduetocardiovasculardiseases
Novisualimpairment 1202 Ref. Ref. 0.03
MildvisualMimildp aviirsmuael nimt pairment 69 0.83 1.20.139, 1.74 0.84,1.75
SeverevisuaSlevimerpe aviirsmuael nimt pairment 52 0.43 1.80.006, 3.07 1.02,3.18
Mortality due to other diseases
Mortalityduetocancers
No visual impairment 3504 Ref. Ref. 0.01
Novisualimpairment 3415 Ref. Ref. 0.33
Mild visual impairment 19 1.58 0.99, 2.51
Mildvisualimpairment 9 0.83 0.39,1.74
Severe visual impairment 9 2.15 0.96, 4.79
Severevisualimpairment 2 0.43 0.06,3.07
Note. CI = confidence interval; HR M= horatzaalirtdy rdautieot; oRoefth. =e rredfiesreeanseces. a Adjusted for age, sex, household
incoNmoev idseucailleim, rpeasiirdminegn tprovince, smoki3n5g0 4status, alcohoRl ecfo.nsumptioRne,f .body mass ind0e.0x1, waist
cirMcuimldfevriesunacel,i msypsatiorlmice natnd diastolic bloo1d9 pressure, ser1u.m58 levels 0o.9f 9f,a2s.t5i1ng glucose, creatinine,
asSpeavretraetev aismuainloimtrpanasirfmereanset, alanine aminot9ransferase, and2 g.1a5mma gl0u.9ta6m,4y.7lt9ransferase, and history
Nooft es.tCroIk=ec,o hnefiadretn cdeisinetaesrev,a lh;HypRe=rtheanzsairodnr,a ttiyop;Re e2f. d=iraebfeerteensc,e d.ayAsldipjuidsteedmfioar, aagne,ds eoxt,hheoru sdeihsoeladsiensc oimnceludedciinleg,
residingprovince,smokingstatus,alcoholconsumption,bodymassindex,waistcircumference,systolicanddiastolic
cancer. b Adjusted for the aforementioned covariates and physical activity.
bloodpressure,serumlevelsoffastingglucose,creatinine,aspartateaminotransferase,alanineaminotransferase,
andgammaglutamyltransferase,andhistoryofstroke,heartdisease,hypertension,type2diabetes,dyslipidemia,
aWndeo tchoernddiusecatseedsi nsctlruadtiinfgiecdan caenr.ablyAsdejus stbeyd fhorotuheseahfooreldm einnticoonmedec olveavreialtse,s asnedx,p haynsdic ablaocdtiyvi tmy. ass index to
identify vulnerable populations for visual impairment. When we stratified the analyses by household
incomWee cleovnedlu, mcteodres tsreavtiefireed vaisnuaalyl siemspbayirhmouenset hwolads ianscsoomcieatleedve wlsi,tshe xh,iagnhderb aoldl-ycamuasses minodretxaltiotyi daemntoinfyg
vtuhlonseer awbilteh ploowpuelra itniocnosmfeo rlevviseulsa l(pim-vpalauirem foern tt.reWndh e=n 0w.0e1)s tbruatti fineodt athmeoannga ltyhsoesse bwyihtho umsiedhdolled (ipn-cvoamluee
lfeovre tlr,emndo r=e 0s.e7v9e) roer vhiisguhaelri imncpoamirme leenvtelws a(ps-avsasluocei afoter dtrewnidth =h 0i.g2h1)e.r Walel- fcoauunsde mthoe ratassliotcyiaatmioonn bgettwhoeseen
wseitvherleo wviesruainl cimompeailremveenlst (apn-dv aallul-ecafoursetr menodrt=ali0ty.0 a1)mbountgn tohtoasem wonitgh tlhoowseer winicthommei dledvleels(p (-HvaRl u=e 3f.6o3r,
t9re5n%d C=I:0 1.7.396), o9r.7h3i)g bhuert innocto wmiethl etvheolsse( pw-vitahl umeidfodrletr (eHndR == 10..6271,) .9W5%e CfoIu: n0.d63t,h 4e.4a8ss) oocri ahtiigohnebr eitnwcoemene
sleevveerles (vHisRu a=l 1im.39p,a 9ir5m%e CnIt: a0n.5d2a, l3l.-7c2a)u (sFeigmuorret a2l)i.t yamongthosewithlowerincomelevels(HR=3.63,
95%CI:1.36,9.73)butnotwiththosewithmiddle(HR=1.67,95%CI:0.63,4.48)orhigherincome
levels(HR=1.39,95%CI:0.52,3.72)(Figure2).
Figure2. Associationbetweenvisualimpairmentandall-causemortalitystratifiedbyincome,sex,and
Figure 2. Association between visual impairment and all-cause mortality stratified by income, sex,
bodymassindex.
and body mass index.
Whenwefurtherstratifiedthestudypopulationwithlowerincomelevelsbysexandbodymass
When we further stratified the study population with lower income levels by sex and body mass
index,moreseverevisualimpairmentwasassociatedwithhigherall-causemortalityamongwomen
index, more severe visual impairment was associated with higher all-cause mortality among women
withlowerincomelevels(p-valuefortrend=0.01)andindividualswithlowerincomelevelsandabody
with lower income levels (p-value for trend = 0.01) and individuals with lower income levels and a
body mass index ≥23 kg/m2 (p-value for trend = 0.01). The association between severe visual
impairment and all-cause mortality was found among women with lower income levels (HR = 3.95,
95% CI: 1.25, 12.46) but not among men with lower income levels (HR = 2.52, 95% CI: 0.35, 18.05). In
addition, the association between severe visual impairment and all-cause mortality was also found
among individuals with lower income levels and a body mass index ≥23 kg/m2 (HR = 4.64, 95% CI:
1.15, 18.74) but not among those with lower income levels and a body mass index <23 kg/m2 (HR =
3.18, 95% CI: 0.79, 12.87) (Figure 2). The confidence intervals were wider in these analyses, because
we further stratified the lower income group by sex or body mass index and, therefore, the sample
size in each stratum was smaller.
Int.J.Environ.Res.PublicHealth2019,16,4386 8of12
massindex≥23kg/m2(p-valuefortrend=0.01). Theassociationbetweenseverevisualimpairment
andall-causemortalitywasfoundamongwomenwithlowerincomelevels(HR=3.95,95%CI:1.25,
12.46) but not among men with lower income levels (HR = 2.52, 95% CI: 0.35, 18.05). In addition,
the association between severe visual impairment and all-cause mortality was also found among
individualswithlowerincomelevelsandabodymassindex≥23kg/m2(HR=4.64,95%CI:1.15,18.74)
butnotamongthosewithlowerincomelevelsandabodymassindex<23kg/m2 (HR=3.18,95%
CI:0.79,12.87)(Figure2). Theconfidenceintervalswerewiderintheseanalyses,becausewefurther
stratifiedthelowerincomegroupbysexorbodymassindexand,therefore,thesamplesizeineach
stratumwassmaller.
Wefoundaninteractiononanadditivescalebetweenvisualimpairmentandnophysicalactivity
onall-causemortality(RERI=1.34,95%CI:0.37,2.30,p-value=0.01). Whenwestratifiedthestudy
populationbyphysicalactivity,anassociationbetweenvisualimpairmentandmortalitywasfound
amongindividualswhodidnotengageinregularphysicalactivity(p-valuefortrend=0.01),butnot
amongthosewhoengagedinregularphysicalactivity(p-valuefortrend=0.41)(Table3).
Table3. Associationsabetweenvisualimpairmentandall-causemortalitystratifiedbyphysicalactivity.
VisualFunction No. ofDeath HR 95%CI p-ValueforTrend
Notengaginginphysicalactivity(None)
Novisualimpairment 5921 Ref. Ref. 0.01
Mildvisualimpairment 31 1.28 0.88,1.86
Severevisualimpairment 15 1.96 1.09,3.55
Engaginginphysicalactivity(≥once/week)
Novisualimpairment 2234 Ref. Ref. 0.41
Mildvisualimpairment 3 0.29 0.04,2.09
Severevisualimpairment 1 1.11 0.16,7.88
Note.CI=confidenceinterval;HR=hazardratio;Ref.=reference.aAdjustedforage,sex,householdincomedecile,
residingprovince,smokingstatus,alcoholconsumption,bodymassindex,waistcircumference,systolicanddiastolic
bloodpressure,serumlevelsoffastingglucose,creatinine,aspartateaminotransferase,alanineaminotransferase,
andgammaglutamyltransferase,andhistoryofstroke,heartdisease,hypertension,type2diabetes,dyslipidemia,
andotherdiseasesincludingcancer.
Whenweexcludedindividualsdiagnosedwithpossiblyvision-threateningconditionsamongthose
classifiedinthenovisualimpairmentgroup,theresultswererobust(SupplementaryMaterialTableS1).
Theresultswerealsorobustintheanalysesincludingindividualswithphysical,auditory,language,
intellectual,andmentaldisabilities,brainlesions,andothertypesofdisability(SupplementaryMaterial
TableS2).
4. Discussion
Wefoundanindependentassociationbetweenvisualimpairmentandmortalityafteradjusting
forpotentialconfounders,whichwasstrongeramongindividualswithlowerincomelevels. However,
whenwestratifiedthestudypopulationbyphysicalactivity,theassociationbetweenvisualimpairment
andmortalitywasnotfoundamongindividualswhoengagedinregularphysicalactivity.
Previousstudieshaveproducedinconsistentresultsregardingtheassociationbetweenvisual
impairmentandmortality, withsomestudiesreportingtheassociation[5–11], whileotherstudies
reporting no association [12–16]. This inconsistency may be due to differences in various factors,
such as the sociodemographic features of the study population, the assessment method of visual
functionandmortality,studydesign,samplesize,andfollow-upperiod. Becausevariousfactorscould
confoundormediatetheassociation(Figure1),inadequateselectionofcovariatesandspecificationof
analyticalmodelsmayalsocontributetotheinconsistency(e.g.,adjustmentofmediatingfactors,such
asdepressivesymptomsandfalls)[5–16]. Inthepresentstudy,weperformedanalysesadjustedfor
potentialconfounders(olderage,systemicdiseasesandconditions,andotherpotentialconfounders)
andnotmediatorsbasedoncarefullyassumedpathways(associationmediatedbyincreasedaccidents
Int.J.Environ.Res.PublicHealth2019,16,4386 9of12
and falls [25], psychological change, such as depression [26], functional independence [27], and
decreasedphysicalactivity[28])(Figure1). Therefore,thepresentstudyprovidesadditionalevidence
fortheindependentassociationbetweenvisualimpairmentandmortality. However,althoughthese
pathwayscanbeaffectedbysocialsupportandresourceavailability, andtherefore, incomelevels,
toourknowledge,nostudieshavereportedastrongerassociationofvisualimpairmentandmortality
inlowerincomelevels. Furtherstudiesarewarrantedtoconfirmtheresultsofthepresentstudy.
Althoughphysicalactivityhasbeenassociatedwithoverallhealth,well-being,anddecreased
mortality[29,30]andreportedlyindividualswithvisualimpairmentandblindnesshavelowerphysical
activitylevels[19,31,32],toourknowledge,onlyonestudyinvestigatedtheinteractionbetweenvisual
impairmentandphysicalactivityonmortality[5]. Inthatstudy,conductedwithaprospectivecohort
inNorway,themortalityriskforbothvisualimpairmentandnophysicalactivitywasmuchhigher
than the sum of the mortality risk for only visual impairment and the mortality risk for only no
physicalactivity. Thisdeparturefromadditivitywasmostsubstantialamongthoseaged<60years[5].
In addition, few studies have evaluated the association between physical activity and decreased
mortality among individuals with visual impairment [28,33]. The results of the present study are
consistentwiththeresultsofthesepreviousstudies[5,28,33]. Theseresultshighlighttheimportanceof
physicalactivityasamatterofconcernwhendesigningpublichealthinterventionsforthevisually
impaired,suchasdevelopingappropriatephysicalactivityprogramsandprovidingregularphysical
activitysessionsthroughpublichealthcenters.
Thereareseverallimitationsinthepresentstudy. First,althoughtheoverallprevalenceofvisual
impairmentwasassessedtobe4.3%intheRepublicofKorea[34],onlyasmallproportionofindividuals
withvisualimpairmentwereincludedinthepresentstudy(359,523withnovisualimpairmentvs.
461withvisualimpairment). However,weconsideredextensivefactorsincludingsociodemographic
features,lifestyle,pastmedicalhistory,physicalexaminations,andclinicallaboratorytestresultsofboth
participantswithandthosewithoutvisualimpairmentandcontrolledforthepossibleconfounding
effectsofthesefactorsinassessingtheassociationbetweenvisualimpairmentandmortality. Second,
instead of evaluating visual function directly during the survey, we used the information from
theNationalHandicappedRegistry[18]toidentifyindividualswithvisualimpairment,leadingto
misclassificationbias. Becausediagnosisbyamedicaldoctorandassessmentofdisabilityareneeded
to register in the National Handicapped Registry, it is possible that some individuals with visual
impairment(especiallythosewithmildvisualimpairment)werenotregisteredintheRegistry,leading
tomisclassificationandshiftingtheresultstowardthenullhypothesis. Inaddition,individualswith
visual field defects and normal central visual acuity (e.g., patients with various diseases, such as
glaucomaandretinitispigmentosa)couldhavebeenincludedinthemildvisualimpairmentgroupin
thepresentstudy,whichmightalsohaveshiftedtheresultstowardthenullhypothesis. Third,the
heterogeneityoftheassociationbetweenvisualimpairmentandmortalitybyphysicalactivitycouldbe
partlyduetoresidualconfoundingofhealthconditions,includingthosepertainingtovisualfunction,
thatlimitphysicalactivity,althoughweadjustedtheanalysesforextensivecovariates. Fourth,the
resultsofnoassociationbetweenvisualimpairmentandmortalityamongindividualswhoengagein
regularphysicalactivityshouldbecautiouslyinterpretedduetothesmallnumberofdeaths,although
thepointestimatesfortheassociationsbetweenvisualimpairmentandmortalitywerenearorless
than1,whichsuggestnoassociation.
However, the present study also has some notable strengths. First, it provides new evidence
forissues(e.g.,interactionbetweenvisualfunctionandphysicalactivityonmortalityandstronger
associationbetweenvisualimpairmentandmortalityamongthosewithlowerincomelevels)thatare
importantforimplementinghealthpoliciesanddesigningpublichealthinterventionsforthevisually
impaired but have been investigated by a limited number of studies. Second, we considered the
severityofvisualimpairmentandassessedthedose-responseassociationbetweenvisualfunctionand
mortality,whichhasnotbeencomprehensivelyevaluateddespiteitsimportanceinestablishingcausal
inference[35].
Int.J.Environ.Res.PublicHealth2019,16,4386 10of12
5. Conclusions
Wefoundanindependentassociationbetweenvisualimpairmentandhighermortalityadjusted
for potential confounders, which was stronger among those with lower income levels. When we
performed stratified analyses by physical activity, the association between visual impairment and
mortalitywasfoundamongindividualswhodidnotengageinregularphysicalactivitybutnotfound
amongthosewhoengagedinregularphysicalactivity. Becauseearlydetectionofvisualimpairment
andeffectivetreatmentofassociatedproblemscanmaximizevisualfunctionforthevisuallyimpaired,
the present study suggests the importance of early detection of visual impairment and adequate
treatmentofassociatedvisualproblems,especiallyamongthosewithlowerincomelevels. Inaddition,
thepresentstudyalsosuggeststheimportanceofphysicalactivityasapublichealthinterventionfor
individualswithvisualimpairmenttoloweradversehealthoutcomessuchasmortality.
SupplementaryMaterials: TheSupplementaryMaterialsareavailableonlineathttp://www.mdpi.com/1660-
4601/16/22/4386/s1,Methods: Assumedcausalpathwayandadjustedcovariates,TableS1. Associationsofvisual
impairmentwithall-causeandcause-specificmortalityamongtheKoreannationalhealthexaminees,excluding
individualsdiagnosedwithvision-threateningconditionsamongthoseclassifiedinthenovisualimpairment
group, Table S2. Associations of visual impairment with all-cause and cause-specific mortality among the
Koreannationalhealthexaminees,includingindividualswithphysical,auditory,language,intellectual,and
mentaldisabilities,brainlesions,andothertypesofdisability. FigureS1. Kaplan-Meiercurvesofsurvivalby
visualfunction.
AuthorContributions:Conceptualization,K.-N.K.,W.K.,J.J.,H.K.,K.H.K.,J.H.S.,andY.J.K.;methodology,K.-N.K.
andS.J.P.;software,K.-N.K.;formalanalysis,K.-N.K.;writing—originaldraftpreparation,K.-N.K.;writing—review
&editing,S.J.P.,W.K.,J.J.,H.K.,K.H.K.,J.H.S.,andY.J.K.;supervision,Y.J.K.;projectadministration,Y.J.K.;funding
acquisition,K.-N.K.andY.J.K.
Funding: ThisstudywassupportedbytheSeoulNationalUniversityHospitalandtheNationalHealthInsurance
ServiceoftheRepublicofKorea(NHIS-2017-4-042).
Acknowledgments: WethanktheNationalHealthInsuranceServiceoftheRepublicofKoreaforprovidingthe
dataforthepresentstudy.
ConflictsofInterest: Theauthorsdeclarenoconflictsofinterest. Thefundingorganizationhadnoroleinthe
design,conduct,orinterpretationoftheresultsofthepresentstudy.
References
1. Park,S.J.; Ahn,S.; Woo,S.J.; Park,K.H.ExtentofExacerbationofChronicHealthConditionsbyVisual
ImpairmentinTermsofHealth-RelatedQualityofLife. JAMAOphthalmol. 2015,133,1267–1275. [CrossRef]
[PubMed]
2. Park,S.J.;Ahn,S.;Park,K.H.BurdenofVisualImpairmentandChronicDiseases. JAMAOphthalmol. 2016,
134,778–784. [CrossRef][PubMed]
3. Köberlein,J.;Beifus,K.;Schaffert,C.;Finger,R.P.Theeconomicburdenofvisualimpairmentandblindness:
Asystematicreview. BMJOpen2013,3,e003471. [CrossRef][PubMed]
4. Bourne,R.R.A.;Flaxman,S.R.;Braithwaite,T.;Cicinelli,M.V.;Das,A.;Jonas,J.B.;Keeffe,J.;Kempen,J.H.;
Leasher,J.;Limburg,H.;etal. Magnitude,temporaltrends,andprojectionsoftheglobalprevalenceof
blindnessanddistanceandnearvisionimpairment: Asystematicreviewandmeta-analysis. LancetGlob.
Health2017,5,e888–e897. [CrossRef]
5. Brunes,A.;Flanders,W.D.;Augestad,L.B.Self-reportedvisualimpairment,physicalactivityandall-cause
mortality: TheHUNTStudy. Scand. J.PublicHealth2017,45,33–41. [CrossRef][PubMed]
6. Age-Related Eye Disease Study 2 Research Group; Papudesu, C.; Clemons, T.E.; Agrón, E.; Chew, E.Y.
AssociationofMortalitywithOcularDiseasesandVisualImpairmentintheAge-RelatedEyeDiseaseStudy
2: Age-RelatedEyeDiseaseStudy2ReportNumber13. Ophthalmology2018,125,512–521. [CrossRef]
7. Ng,S.K.;Kahawita,S.;Andrew,N.H.;Henderson,T.;Craig,J.E.;Landers,J.AssociationofVisualImpairment
and All-Cause 10-Year Mortality Among Indigenous Australian Individuals Within Central Australia:
TheCentralAustralianOcularHealthStudy. JAMAOphthalmol. 2018,136,534–537. [CrossRef]
Int.J.Environ.Res.PublicHealth2019,16,4386 11of12
8. Hong,Y.A.;Kim,S.Y.;Kim,S.H.;Kim,Y.O.;Jin,D.C.;Song,H.C.;Choi,E.J.;Kim,Y.L.;Kim,Y.S.;Kang,S.W.;
etal. TheAssociationofVisualImpairmentwithClinicalOutcomesinHemodialysisPatients. Medicine2016,
95,e3591. [CrossRef]
9. Siantar,R.G.; Cheng,C.Y.; GemmyCheung,C.M.; Lamoureux,E.L.; Ong,P.G.; Chow,K.Y.; Mitchell,P.;
Aung,T.;Wong,T.Y.;Cheung,C.Y.ImpactofVisualImpairmentandEyediseasesonMortality:TheSingapore
MalayEyeStudy(SiMES).Sci. Rep. 2015,5,16304. [CrossRef]
10. Thomas,B.J.; Sanders,D.S.; Oliva,M.S.; Orrs,M.S.; Glick,P.; Ruit,S.; Chen,W.; Luoto,J.; Tasfaw,A.K.;
Tabin,G.C.Blindness,cataractsurgeryandmortalityinEthiopia. Br. J.Ophthalmol. 2016,100,1157–1162.
[CrossRef]
11. Liu,E.; Ng,S.K.; Kahawita,S.; Andrew,N.H.; Henderson,T.; Craig,J.E.; Landers,J.Ten-yearall-cause
mortalityanditsassociationwithvisionamongIndigenousAustralianswithinCentralAustralia:TheCentral
AustralianOcularHealthStudy. Clin. Experiment. Ophthalmol. 2017,45,348–356. [CrossRef]
12. Zhu,Z.; Wang,L.; Young,C.A.; Huang,S.; Chang,B.H.W.; He,M.Cataract-RelatedVisualImpairment
CorrectedbyCataractSurgeryand10-YearMortality: TheLiwanEyeStudy. Investig. Ophthalmol. Vis. Sci.
2016,57,2290–2295. [CrossRef][PubMed]
13. Schubert,C.R.;Fischer,M.E.;Pinto,A.A.;Klein,B.E.K.;Klein,R.;Tweed,T.S.;Cruickshanks,K.J.Sensory
ImpairmentsandRiskofMortalityinOlderAdults. J.Gerontol. ABiol. Sci. Med. Sci. 2017,72,710–715.
[CrossRef][PubMed]
14. Kuang,T.M.;Tsai,S.Y.;Liu,C.J.L.;Lee,S.M.;Hsu,W.M.;Chou,P.Theassociationofvisualimpairmentand
3-yearmortalityamongtheelderlyinTaiwan: TheShihpaiEyeStudy. J.Chin. Med. Assoc. 2015,78,177–181.
[CrossRef][PubMed]
15. Mitoku,K.;Masaki,N.;Ogata,Y.;Okamoto,K.Visionandhearingimpairments,cognitiveimpairmentand
mortalityamonglong-termcarerecipients: Apopulation-basedcohortstudy. BMCGeriatr. 2016,16,112.
[CrossRef][PubMed]
16. Yamada,Y.;Denkinger,M.D.;Onder,G.;vanderRoest,H.G.;Finne-Soveri,H.;Bernabei,R.;Topinkova,E.
Joint Associations of Dual Sensory Impairment and No-Activity Involvement with 1-Year Mortality in
NursingHomes: ResultsfromtheSHELTERStudy. J.Gerontol. ABiol. Sci. Med. Sci. 2016,71,643–648.
[CrossRef][PubMed]
17. Seong, S.C.; Kim, Y.Y.; Park, S.K.; Khang, Y.H.; Kim, H.C.; Park, J.H.; Kang, H.J.; Do, C.H.; Song, J.S.;
Lee,E.J.;etal. Cohortprofile: TheNationalHealthInsuranceService-NationalHealthScreeningCohort
(NHIS-HEALS)inKorea. BMJOpen2017,7,e016640. [CrossRef]
18. Song,S.J.;Han,K.;Choi,K.S.;Ko,S.H.;Rhee,E.J.;Park,C.Y.;Park,J.Y.;Lee,K.U.;Ko,K.S.TaskForceTeam
forDiabetesFactSheetoftheKoreanDiabetesAssociationTrendsindiabeticretinopathyandrelatedmedical
practicesamongtype2diabetespatients: ResultsfromtheNationalInsuranceServiceSurvey2006–2013.
J.Diabetes. Investig. 2018,9,173–178. [CrossRef]
19. Williams,G.;Aggio,D.;Stubbs,B.;Pardhan,S.;Gardner,B.;Smith,L.Physicalactivitylevelsinchildren
withsensoryproblems: Cross-sectionalanalysesfromtheMillenniumCohortStudy. Disabil. HealthJ.2018,
11,58–61. [CrossRef]
20. Estevez,J.;Kaidonis,G.;Henderson,T.;Craig,J.E.;Landers,J.Associationofdisease-specificcausesofvisual
impairmentand10-yearmortalityamongstIndigenousAustralians: TheCentralAustralianOcularHealth
Study. Clin. Experiment. Ophthalmol. 2018,46,18–24. [CrossRef]
21. Korpelainen, R.; Lämsä, J.; Kaikkonen, K.M.; Korpelainen, J.; Laukkanen, J.; Palatsi, I.; Takala, T.E.;
Ikäheimo,T.M.;Hautala,A.J.Exercisecapacityandmortality—Afollow-upstudyof3033subjectsreferred
toclinicalexercisetesting. Ann. Med. 2016,48,359–366. [CrossRef][PubMed]
22. Wang,A.G.Visualimpairmentandmortality: Aretheyrelated? J.Chin. Med. Assoc. 2015,78,137–138.
[CrossRef][PubMed]
23. Andersson,T.;Alfredsson,L.;Källberg,H.;Zdravkovic,S.;Ahlbom,A.Calculatingmeasuresofbiological
interaction. Eur. J.Epidemiol. 2005,20,575–579. [CrossRef][PubMed]
24. Knol,M.J.;VanderWeele,T.J.;Groenwold,R.H.H.;Klungel,O.H.;Rovers,M.M.;Grobbee,D.E.Estimating
measuresofinteractiononanadditivescaleforpreventiveexposures. Eur. J.Epidemiol. 2011,26,433–438.
[CrossRef][PubMed]
Int.J.Environ.Res.PublicHealth2019,16,4386 12of12
25. Skalska, A.; Wizner, B.; Piotrowicz, K.; Klich-Ra˛czka, A.; Klimek, E.; Mossakowska, M.; Rowin´ski, R.;
Kozak-Szkopek,E.;Józ´wiak,A.;Ga˛sowski,J.;etal. Theprevalenceoffallsandtheirrelationtovisualand
hearingimpairmentsamonganation-widecohortofolderPoles. Exp. Gerontol. 2013,48,140–146. [CrossRef]
[PubMed]
26. Zheng,D.D.;Christ,S.L.;Lam,B.L.;Arheart,K.L.;Galor,A.;Lee,D.J.Increasedmortalityriskamongthe
visuallyimpaired: Therolesofmentalwell-beingandpreventivecarepractices. Investig. Ophthalmol. Vis.Sci.
2012,53,2685–2692. [CrossRef]
27. Christ,S.L.; Zheng,D.D.; Swenor,B.K.; Lam,B.L.; West,S.K.; Tannenbaum,S.L.; Muñoz,B.E.; Lee,D.J.
Longitudinalrelationshipsamongvisualacuity,dailyfunctionalstatus,andmortality: TheSalisburyEye
EvaluationStudy. JAMAOphthalmol. 2014,132,1400–1406. [CrossRef]
28. Loprinzi,P.D.;Joyner,C.Accelerometer-determinedphysicalactivityandmortalityinanationalprospective
cohortstudy: Considerationsbyvisualacuity. Prev. Med. 2016,87,18–21. [CrossRef]
29. Lear, S.A.; Hu, W.; Rangarajan, S.; Gasevic, D.; Leong, D.; Iqbal, R.; Casanova, A.; Swaminathan, S.;
Anjana,R.M.;Kumar,R.;etal. Theeffectofphysicalactivityonmortalityandcardiovasculardiseasein
130000peoplefrom17high-inocme,middle-income,andlow-incomecountries: ThePUREstudy. Lancet
2017,390,2643–2654. [CrossRef]
30. Kikuchi,H.;Inoue,S.;Lee,I.M.;Odagiri,Y.;Sawada,N.;Inoue,M.;Tsugane,S.ImpactofModerate-Intensity
andVigorous-IntensityPhysicalActivityonMortality. Med. Sci. SportsExerc. 2018,50,715–721. [CrossRef]
31. Barbosa Porcellis da Silva, R.; Marques, A.C.; Reichert, F.F. Objectively measured physical activity in
Brazilianswithvisualimpairment: Descriptionandassociatedfactors. Disabil. Rehabil. 2018,40,2131–2137.
[CrossRef][PubMed]
32. Ong,S.R.;Crowston,J.G.;Loprinzi,P.D.;Ramulu,P.Y.Physicalactivity,visualimpairment,andeyedisease.
Eye2018,32,1296–1303. [CrossRef][PubMed]
33. Kulmala,J.;Era,P.;Törmäkangas,T.;Pärssinen,O.;Rantanen,T.;Heikkinen,E.Visualacuityandmortality
inolderpeopleandfactorsonthepathway. OphthalmicEpidemiol. 2008,15,128–134. [CrossRef]
34. Rim,T.H.T.;Nam,J.S.;Choi,M.;Lee,S.C.;Lee,C.S.Prevalenceandriskfactorsofvisualimpairmentand
blindnessinKorea: TheFourthKoreaNationalHealthandNutritionExaminationSurveyin2008–2010.
ActaOphthalmol. 2014,92,e317–e325. [CrossRef][PubMed]
35. Zhang,T.;Jiang,W.;Song,X.;Zhang,D.Theassociationbetweenvisualimpairmentandtheriskofmortality:
A meta-analysis of prospective studies. J. Epidemiol. Community Health 2016, 70, 836–842. [CrossRef]
[PubMed]
©2019bytheauthors. LicenseeMDPI,Basel,Switzerland. Thisarticleisanopenaccess
articledistributedunderthetermsandconditionsoftheCreativeCommonsAttribution
(CCBY)license(http://creativecommons.org/licenses/by/4.0/).
